Trials / Terminated
TerminatedNCT00215033
Relationship Between EBV and PTLD
Relationship Between Quantitative Epstein-Bar Viral(EBV) Titres and Post-Transplant Lymphoproliferative Disease
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 160 (actual)
- Sponsor
- Children's Healthcare of Atlanta · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the significance of an elevated quantitative EBV PCR and to determine the relationship between a EBV PCR value and the risk of developing PTLD.
Detailed description
The relationship between Epstein-Barr virus and lymphoproliferative disease has been established, particularly in the immuno-suppressed patient. Over the past several years a quantitative EBV PCR lab test has been established. Unfortunately, the significance of an elevated test remains unclear. The relationship of a particular EBV PCR value and the risk of developing PTLD is unknown. The primary aims will be to determine the significance of an elevated quantitative EBV PCR and to determine the relationship between a EBV PCR value and the risk of developing PTLD. The study will be conducted through a retrospective chart review of approximately 160 patients and we will look at postoperative data including Quantitative EBV PCR results, the presence / absence of PTLD and the treatment of PTLD and results of EBV PCR with treatment.
Conditions
Timeline
- Start date
- 2005-04-01
- Completion
- 2006-05-01
- First posted
- 2005-09-22
- Last updated
- 2012-03-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00215033. Inclusion in this directory is not an endorsement.